1 4 8 11-TETRAAZACYCLOTETRADECANE 98% (GC) (C15-1228-520)

Catalog No.: C15-1228-520
Mfr. No.: 259160-5G
Mfr. Name: Sigma-Aldrich
Qty/UOM: 5
UOM: GR

Price: $366.48

List Price: $407.20

1,4,8,11-Tetraazacyclotetradecane is an azamacrocycle that forms more stable metal complexes as compared to open chain ligands. Application 1,4,8,11-Tetraazacyclotetradecane (cyclam) can be used as a ligand in the synthesis of: Cyanide-bridged Fe

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

General description

1,4,8,11-Tetraazacyclotetradecane is an azamacrocycle that forms more stable metal complexes as compared to open chain ligands.

Application

1,4,8,11-Tetraazacyclotetradecane (cyclam) can be used as a ligand in the synthesis of:

Cyanide-bridged Fe^III-Cu^II complexes.
Zinc fenamate complexes [Zn(cyclam)(fen)₂] possessing antimicrobial properties, fen = fenamic acid.
Zn(II) complexes with flufenamic acid (flu), [Zn(cyclam)(flu)₂].
Polyoxometalate-metal organic extended framework, for example [{Cu(cyclam)}₃(W₇O₂₄)].15.5.H₂O.

UPC:: 51284048
Condition:: New
Availability:: 3-5 Days
Weight:: 1.00 Ounces
HazmatClass:: No
MPN:: 259160-5G
CAS:: 295-37-4

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."